(Q52568016)

3 May 2018

title

Widespread and abundant alpha-synuclein pathology in a neurologically unimpaired subject. (English)

1 reference

3 May 2018

0 references

1 reference

3

Markku Tervahauta

1 reference

3 May 2018

author name string

Laura Parkkinen

series ordinal

1

1 reference

3 May 2018

Tuula Pirttilä

series ordinal

2

1 reference

3 May 2018

Irina Alafuzoff

series ordinal

4

1 reference

3 May 2018

publication date

1 December 2005

1 reference

3 May 2018

published in

Neuropathology

1 reference

3 May 2018

volume

25

1 reference

3 May 2018

issue

4

1 reference

3 May 2018

page(s)

304-314

1 reference

3 May 2018

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

alpha-Synuclein locus triplication causes Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

A Drosophila model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Alpha-synuclein pathology is highly dependent on the case selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

beta-amyloid load is not influenced by the severity of cardiovascular disease in aged and demented patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Lewy bodies in the lateral hypothalamus: do they imply neuronal loss?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Neuronal activity and early neurofibrillary tangles in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Stability of cell size and nucleolar size in Lewy body containing neurons of substantia nigra in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Contribution of somal Lewy bodies to neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Numerous and widespread alpha-synuclein-negative Lewy bodies in an asymptomatic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Lewy body cortical involvement may not always predict dementia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Lewy-body formation is an aggresome-related process: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Pathology and neurotransmitter abnormalities of dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Activated microglia in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

DNA fragmentation in human substantia nigra: apoptosis or perimortem effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

Induction of neuronal death by α-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2005.00644.X

10.1111/J.1440-1789.2005.00644.X

21 January 2018

Identifiers

DOI

1 reference

3 May 2018

1 reference

3 May 2018